CsA plus MTX plus MMF plus low-dose ATG protocal for GVHD prophylaxis in unrelated donor hematopoietic stem cell transplantation.

被引：0
|
作者：
Liu, QF [1 ]
Sun, J [1 ]
Zhang, Y [1 ]
Liu, XL [1 ]
Xu, D [1 ]
机构：
[1] Nanfang Hosp, Dept Hematol, Guangzhou, Peoples R China
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5617
引用
收藏
页码：473B / 473B
页数：1
相关论文
共 50 条
  • [1] Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
    Kharfan-Dabaja, M. A.
    Parody, R.
    Perkins, J.
    Lopez-Godino, O.
    Lopez-Corral, L.
    Vazquez, L.
    Caballero, D.
    Falantes, J.
    Shapiro, J.
    Orti, G.
    Barba, P.
    Valcarcel, D.
    Esquirol, A.
    Martino, R.
    Pinana, J. L.
    Solano, C.
    Tsalatsanis, A.
    Pidala, J.
    Anasetti, C.
    Perez-Simon, J. A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (03) : 438 - 444
  • [2] Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
    M A Kharfan-Dabaja
    R Parody
    J Perkins
    O Lopez-Godino
    L Lopez-Corral
    L Vazquez
    D Caballero
    J Falantes
    J Shapiro
    G Ortí
    P Barba
    D Valcárcel
    A Esquirol
    R Martino
    J L Piñana
    C Solano
    A Tsalatsanis
    J Pidala
    C Anasetti
    J A Perez-Simón
    Bone Marrow Transplantation, 2017, 52 : 438 - 444
  • [3] Quadruple therapy with CsA, MTX, MMF and ATG and triple therapy with CsA, MTX and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation
    Fan, ZP
    Yi, ZS
    Liu, QF
    Sun, J
    Xu, D
    Zhang, Y
    Wei, YQ
    Ye, CX
    BLOOD, 2005, 106 (11) : 408B - 409B
  • [4] Unrelated donor stem cell transplantation in children:: Low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole, iv-immunoglobutin and ATG
    Finckenstein, FG
    Zabelina, T
    Dürken, M
    Dahlke, J
    Kröger, N
    Krüger, W
    Janka-Schaub, G
    Erttmann, R
    Zander, AR
    Kabisch, H
    KLINISCHE PADIATRIE, 2002, 214 (04): : 206 - 211
  • [5] Low-Dose Cyclosporine (CsA) Plus Mycophenolate Mofetil (MMF) and Prednisolone (Pred) Triple Immunosuppressive Protocol in Renal Transplantation.
    Xiang, H.
    Xue, W.
    Tian, P.
    Ding, X.
    Pan, X.
    Yan, H.
    Hou, J.
    Feng, X.
    Tian, X.
    Ding, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 315 - 316
  • [6] Sirolimus (RAP), tacrolimus (FK), and low dose methotrexate (MTX) for GVHD prophylaxis in mismatched related donor or unrelated donor transplantation.
    Antin, JH
    Lee, SJ
    Neuberg, D
    Alyea, E
    Ritz, J
    Soiffer, RJ
    BLOOD, 2001, 98 (11) : 857A - 857A
  • [7] Ptcy-ATG-CSA Vs. ATG-MMF-CSA for Gvhd Prevention for 10/10 HLA Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
    Salas, Maria Queralt
    Carreira, Abel Santos
    Atenafu, Eshetu G.
    Law, Arjun D.
    Lam, Wilson
    Pasic, Ivan
    Chen, Carol
    Kim, Dennis Dong Hwan
    Michelis, Fotios, V
    Gerbitz, Armin
    Lipton, Jeffrey H.
    Kumar, Rajat
    Mattsson, Jonas
    Viswabandya, Auro
    BLOOD, 2022, 140 : 4878 - 4879
  • [8] Comparison of cyclosporine (CSA) plus methylprednisolone (MePred) vs CSA plus methotrexate (MTX) for GvHD prophylaxis in HLA identical allogenic bone marrow transplantation (BMT)
    Zorsky, P
    Ballester, O
    Goldstein, S
    Hiemenz, J
    Janssen, W
    Fields, K
    Elfenbein, G
    BLOOD, 1995, 86 (10) : 1573 - 1573
  • [9] Intravenous mycophenolate mofetil plus prednisolone and cyclosporine in the prophylaxis of GvHD after stem cell transplantation.
    Kiehl, MG
    Armstrong, V
    Basara, N
    Blau, IW
    Oellerich, M
    Fauser, AA
    BLOOD, 1999, 94 (10) : 153A - 153A
  • [10] In vivo T cell depletion with ATG reduces GVHD in unrelated donor stem cell transplantation.
    Finke, J
    Bertz, H
    Veelken, H
    Wäsch, R
    Behringer, D
    Illerhaus, G
    von Kalle, C
    Kunzmann, R
    Lang, H
    Schwabe, M
    Mertelsmann, R
    BLOOD, 1999, 94 (10) : 713A - 713A
12345